Newswire

The first 14 days: How specialty programs set patients up for success

As specialty medicines play a growing role in healthcare, the patient journey that follows is equally critical. The first 14 days after a patient starts a specialty medication can significantly influence adherence and overall treatment outcomes. This initial period is crucial for establishing a strong foundation for patient success, as it often determines whether patients will continue their therapy or face interruptions that could jeopardize their health.

In this context, specialty pharmacy programs are increasingly being designed to provide comprehensive support, including education, monitoring, and personalized care plans. These programs not only facilitate medication access but also address potential barriers that patients may encounter. The implications for pharma professionals are profound, as effective patient support strategies can lead to improved adherence rates, better health outcomes, and ultimately, enhanced market performance for specialty products.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →